BR9809396A - Método de tratamento de doenças de cicatrização vascular progressivas - Google Patents
Método de tratamento de doenças de cicatrização vascular progressivasInfo
- Publication number
- BR9809396A BR9809396A BR9809396-7A BR9809396A BR9809396A BR 9809396 A BR9809396 A BR 9809396A BR 9809396 A BR9809396 A BR 9809396A BR 9809396 A BR9809396 A BR 9809396A
- Authority
- BR
- Brazil
- Prior art keywords
- pps
- treatment
- progressive vascular
- patient
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Patente de Invenção: <B>"MéTODO DE TRATAMENTO DE DOENçAS DE CICATRIZAçãO VASCULAR PROGRESSIVAS<D>". Um método de tratamento de um paciente mamífero que sofre de uma doença de cicatrização vascular progressiva (CPVSD), particularmente doenças arterioescleróticas tal como ateroesclerose, para cessar ou pelo menos diminuir substancialmente o progresso da doença e levar a resolução e/ou diminuição de lesões e cicatrizações já formadas. O método consiste da administração ao paciente de uma composição farmacêutica contendo uma quantidade eficaz de polissulfato de pentosano (PPS) ou um seu sal farmaceuticamente aceitável. A via oral de administração é preferida, com a dosagem diária de PPS ou de sal de PPS variando de cerca de 5 a cerca de30 mg/kg de peso de corpo do paciente, ou cerca de 350 a cerca de 2000 mg por dias em pacientes humanos adultos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/840,777 US20010005720A1 (en) | 1995-06-07 | 1997-04-16 | Method of treating chronic progressive vascular scarring diseases |
| PCT/US1998/007517 WO1998046237A1 (en) | 1997-04-16 | 1998-04-10 | Method of treating chronic progressive vascular scarring diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9809396A true BR9809396A (pt) | 2000-06-13 |
Family
ID=25283204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9809396-7A BR9809396A (pt) | 1997-04-16 | 1998-04-10 | Método de tratamento de doenças de cicatrização vascular progressivas |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20010005720A1 (pt) |
| EP (1) | EP0986392A4 (pt) |
| JP (1) | JPH1149802A (pt) |
| KR (1) | KR20010006511A (pt) |
| CN (1) | CN1259871A (pt) |
| AR (1) | AR008559A1 (pt) |
| AU (1) | AU750182B2 (pt) |
| BR (1) | BR9809396A (pt) |
| CA (1) | CA2285950A1 (pt) |
| HU (1) | HUP0003256A3 (pt) |
| IL (1) | IL132389A0 (pt) |
| NO (1) | NO995024L (pt) |
| NZ (1) | NZ500527A (pt) |
| SK (1) | SK142599A3 (pt) |
| TW (1) | TW557213B (pt) |
| WO (1) | WO1998046237A1 (pt) |
| ZA (1) | ZA982246B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005292202A1 (en) * | 2004-10-01 | 2006-04-13 | Keryx Biopharmaceuticals, Inc. | Methods using glycosaminoglycans for the treatment of kidney disease |
| WO2010103837A1 (ja) | 2009-03-11 | 2010-09-16 | ゼライス株式会社 | アテローム性動脈硬化症の進行抑制薬・予防薬・血中コレステロール低下薬・機能性食品・特定保健用食品 |
| CN102327282A (zh) * | 2010-09-01 | 2012-01-25 | 吴洪 | 戊糖多聚硫酸酯用于制备治疗糖尿病肾病的药物中的用途 |
| KR102559743B1 (ko) | 2016-08-31 | 2023-07-25 | 오지 홀딩스 가부시키가이샤 | 산성 자일로올리고당의 제조 방법 및 산성 자일로올리고당 |
| JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
| JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
| WO2018221547A1 (ja) | 2017-05-31 | 2018-12-06 | 王子ホールディングス株式会社 | 保湿外用剤 |
| WO2019054344A1 (ja) | 2017-09-12 | 2019-03-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法 |
| HUE062342T2 (hu) | 2017-12-20 | 2023-10-28 | Oji Holdings Corp | Pentozán-poliszulfát, valamint pentozán-poliszulfátot tartalmazó gyógyszerek |
| WO2023070164A1 (en) * | 2021-10-28 | 2023-05-04 | Paradigm Biopharmaceuticals Ltd | Treatment of heart failure with preserved ejection fraction |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820693A (en) * | 1986-05-22 | 1989-04-11 | Angiogenics, Ltd. | Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
| US5643892A (en) * | 1995-06-07 | 1997-07-01 | Baker Norton Pharmaceuticals, Inc. | Method of treating chronic progressive vascular diseases |
-
1997
- 1997-04-16 US US08/840,777 patent/US20010005720A1/en not_active Abandoned
-
1998
- 1998-03-17 ZA ZA982246A patent/ZA982246B/xx unknown
- 1998-03-26 AR ARP980101391A patent/AR008559A1/es unknown
- 1998-04-02 JP JP10108762A patent/JPH1149802A/ja active Pending
- 1998-04-10 IL IL13238998A patent/IL132389A0/xx unknown
- 1998-04-10 WO PCT/US1998/007517 patent/WO1998046237A1/en not_active Application Discontinuation
- 1998-04-10 SK SK1425-99A patent/SK142599A3/sk unknown
- 1998-04-10 HU HU0003256A patent/HUP0003256A3/hu unknown
- 1998-04-10 AU AU72482/98A patent/AU750182B2/en not_active Ceased
- 1998-04-10 NZ NZ500527A patent/NZ500527A/en unknown
- 1998-04-10 KR KR1019997009601A patent/KR20010006511A/ko not_active Application Discontinuation
- 1998-04-10 EP EP98919769A patent/EP0986392A4/en not_active Withdrawn
- 1998-04-10 BR BR9809396-7A patent/BR9809396A/pt unknown
- 1998-04-10 CN CN98805235A patent/CN1259871A/zh active Pending
- 1998-04-10 CA CA002285950A patent/CA2285950A1/en not_active Abandoned
- 1998-04-15 TW TW087105754A patent/TW557213B/zh active
-
1999
- 1999-10-15 NO NO995024A patent/NO995024L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR008559A1 (es) | 2000-01-19 |
| AU7248298A (en) | 1998-11-11 |
| KR20010006511A (ko) | 2001-01-26 |
| NO995024L (no) | 1999-12-13 |
| TW557213B (en) | 2003-10-11 |
| CN1259871A (zh) | 2000-07-12 |
| HUP0003256A3 (en) | 2001-12-28 |
| IL132389A0 (en) | 2001-03-19 |
| US20010005720A1 (en) | 2001-06-28 |
| ZA982246B (en) | 1998-09-17 |
| JPH1149802A (ja) | 1999-02-23 |
| CA2285950A1 (en) | 1998-10-22 |
| NZ500527A (en) | 2001-10-26 |
| SK142599A3 (en) | 2001-12-03 |
| NO995024D0 (no) | 1999-10-15 |
| HUP0003256A2 (hu) | 2001-02-28 |
| WO1998046237A1 (en) | 1998-10-22 |
| AU750182B2 (en) | 2002-07-11 |
| EP0986392A1 (en) | 2000-03-22 |
| EP0986392A4 (en) | 2000-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
| BR0013540A (pt) | Formulações farmacêuticas e seu uso na prevenção de acidente vascular cerebral, diabetes e/ou falha de coração congestiva | |
| KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
| PT1212060E (pt) | Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson | |
| BRPI0613731A2 (pt) | composição farmacêutica, recipiente enchido previamente, bem como uso de um açúcar para aprimorar a recuperação e/ou aumentar a atividade biológica de um membro da superfamìlia tgf-beta | |
| NL970006I1 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
| Perkins | Apnea with intramuscular colistin therapy | |
| BR9809396A (pt) | Método de tratamento de doenças de cicatrização vascular progressivas | |
| DE69333387D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Norastemizol. | |
| KR970025615A (ko) | 암 전이 억제제 | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| JPH06329541A (ja) | 糖尿病性腎症治療用スロデキサイド含有医薬 | |
| BR9809694A (pt) | Processo e composição para administração de taxanos oralmente a pacientes humanos | |
| BR9704114A (pt) | Processo de tratamento de doenças vasculares progressivas crÈnicas | |
| AU2336100A (en) | New use of melagatran | |
| BR0013252A (pt) | Micofenolato mofetila em associação com peg-ifn-alfa | |
| BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
| US5716646A (en) | Methods and compositions for treating arthritis | |
| KR900007434A (ko) | 시스타틴을 유효 성분으로하는 치료제 | |
| AR002727A1 (es) | El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. | |
| KR970005283A (ko) | 심근경색발생 후의 환자를 처치하기 위한 서트랄린의 용도 | |
| DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| BR0009327A (pt) | Composição farmacêutica para a terapia de sintomas do trato urinário inferior | |
| KR890001558A (ko) | 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염 | |
| Vaidyanathan et al. | Dosage of once-daily gentamicin in spinal cord injury patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |